Hans‐Martin Otten

1.9k total citations
28 papers, 1.1k citations indexed

About

Hans‐Martin Otten is a scholar working on Internal Medicine, Genetics and Surgery. According to data from OpenAlex, Hans‐Martin Otten has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Internal Medicine, 10 papers in Genetics and 6 papers in Surgery. Recurrent topics in Hans‐Martin Otten's work include Venous Thromboembolism Diagnosis and Management (13 papers), Hemoglobinopathies and Related Disorders (8 papers) and Central Venous Catheters and Hemodialysis (6 papers). Hans‐Martin Otten is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (13 papers), Hemoglobinopathies and Related Disorders (8 papers) and Central Venous Catheters and Hemodialysis (6 papers). Hans‐Martin Otten collaborates with scholars based in Netherlands, Italy and Curacao. Hans‐Martin Otten's co-authors include Martin H. Prins, Marcello Di Nisio, Bart J. Biemond, Erfan Nur, John‐John B. Schnog, Dick J. Richel, Dees P. M. Brandjes, Hugo Ten Cate, Noemi Ferrante and Anne WS Rutjes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

Hans‐Martin Otten

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans‐Martin Otten Netherlands	13	595	348	324	308	262	28	1.1k
Krystyna Zawilska Poland	14	462 0.8×	412 1.2×	537 1.7×	151 0.5×	65 0.2×	90	1.2k
Giuseppe Cella Italy	21	441 0.7×	399 1.1×	533 1.6×	202 0.7×	38 0.1×	87	1.4k
M Samama France	17	664 1.1×	547 1.6×	473 1.5×	78 0.3×	82 0.3×	58	1.4k
Nelly G. Adel United States	9	223 0.4×	193 0.6×	108 0.3×	116 0.4×	79 0.3×	27	1.4k
Karin Strandberg Sweden	19	615 1.0×	726 2.1×	507 1.6×	85 0.3×	29 0.1×	72	1.4k
Meyer‐Michel Samama France	19	1.0k 1.7×	851 2.4×	388 1.2×	54 0.2×	89 0.3×	62	1.6k
Guido Luzzatto Italy	14	204 0.3×	113 0.3×	453 1.4×	114 0.4×	28 0.1×	47	797
Irving B. Mink United States	14	162 0.3×	113 0.3×	167 0.5×	63 0.2×	66 0.3×	25	639
Philip W. Friederich Netherlands	19	547 0.9×	453 1.3×	1.2k 3.8×	245 0.8×	11 0.0×	23	2.0k
Roumen Nakov Germany	13	364 0.6×	338 1.0×	137 0.4×	14 0.0×	47 0.2×	26	864

Countries citing papers authored by Hans‐Martin Otten

Since Specialization

Citations

This map shows the geographic impact of Hans‐Martin Otten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Martin Otten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Martin Otten more than expected).

Fields of papers citing papers by Hans‐Martin Otten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Martin Otten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Martin Otten. The network helps show where Hans‐Martin Otten may publish in the future.

Co-authorship network of co-authors of Hans‐Martin Otten

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Martin Otten. A scholar is included among the top collaborators of Hans‐Martin Otten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Martin Otten. Hans‐Martin Otten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koolen, Marijn, Hans‐Martin Otten, Helle‐Brit Fiebrich, et al.. (2025). Feasibility and clinical outcomes of imatinib personalized dosing in gastrointestinal stromal tumor patients.. Journal of Clinical Oncology. 43(16_suppl). 11521–11521. 1 indexed citations

Bosch, Floris T.M., Pieter W. Kamphuisen, Stefano Barco, et al.. (2025). Management of recurrent venous thromboembolism during anticoagulant treatment in patients with cancer: a prospective cohort study. Journal of Thrombosis and Haemostasis. 23(12). 3932–3939.

Bosch, Floris T.M., Elena Campello, Frits I. Mulder, et al.. (2023). Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study. Journal of Thrombosis and Haemostasis. 21(10). 2863–2872. 4 indexed citations

Otten, Hans‐Martin, et al.. (2022). Idiopathic hyperammonemic encephalopathy secondary to gemcitabine–cisplatin treatment. Cancer Chemotherapy and Pharmacology. 90(5). 417–419.

Mulder, Frits I., Marc Carrier, Philippe Robin, et al.. (2020). Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis. Journal of Thrombosis and Haemostasis. 18(10). 2622–2628. 11 indexed citations

Werkhoven, Erik van, Hans‐Martin Otten, Andries M. Bergman, et al.. (2019). Neutropenia and docetaxel exposure in metastatic castration‐resistant prostate cancer patients: A meta‐analysis and evaluation of a clinical cohort. Cancer Medicine. 8(4). 1406–1415. 13 indexed citations

Joore, Manuela, Hugo Ten Cate, Karina Meijer, et al.. (2018). Clinical and economic impact of compression in the acute phase of deep vein thrombosis. Journal of Thrombosis and Haemostasis. 16(8). 1555–1563. 14 indexed citations

Nur, Erfan, Bart J. Biemond, G J van Mierlo, et al.. (2013). Nucleosomes and neutrophil activation in sickle cell disease painful crisis. Haematologica. 98(11). 1797–1803. 61 indexed citations

Nur, Erfan, Dees P. M. Brandjes, Tom Teerlink, et al.. (2012). N-acetylcysteine reduces oxidative stress in sickle cell patients. Annals of Hematology. 91(7). 1097–1105. 67 indexed citations

10.

Nisio, Marcello Di, Ettore Porreca, Noemi Ferrante, et al.. (2012). Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database of Systematic Reviews. 12(2). CD008500–CD008500. 209 indexed citations

11.

Nur, Erfan, Dirk R. de Waart, John‐John B. Schnog, et al.. (2011). Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(11). 1412–1417. 38 indexed citations

12.

Nur, Erfan, et al.. (2011). Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. American Journal of Hematology. 86(6). 484–489. 162 indexed citations

13.

Doormaal, Frederiek F van, Marcello Di Nisio, Hans‐Martin Otten, et al.. (2011). Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer. Journal of Clinical Oncology. 29(15). 2071–2076. 126 indexed citations

14.

Nur, Erfan, Bart J. Biemond, Anton P. van Zanten, et al.. (2010). Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis. American Journal of Hematology. 85(11). 902–904. 15 indexed citations

15.

Nur, Erfan, Dees P. M. Brandjes, John‐John B. Schnog, et al.. (2010). Plasma levels of advanced glycation end products are associated with haemolysis‐related organ complications in sickle cell patients. British Journal of Haematology. 151(1). 62–69. 39 indexed citations

16.

Nur, Erfan, Rudi de Waart, Hans‐Martin Otten, et al.. (2009). Increased Efflux of Oxidized Glutathione (GSSG) Causes Glutathione Depletion in Sickle Erythrocytes.. Blood. 114(22). 1542–1542. 1 indexed citations

17.

Doormaal, Frederiek F van, Hans‐Martin Otten, & H.R. Büller. (2007). SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM. THE TROUSSEAU INVESTIGATORS. Journal of Thrombosis and Haemostasis. 5. P–T. 1 indexed citations

18.

Otten, Hans‐Martin & Martin H. Prins. (2001). A number needed to screen and cost-effectiveness analysis of the SOMIT-data.. PubMed. 31 Suppl 1. 40–2. 4 indexed citations

19.

Otten, Hans‐Martin & Martin H. Prins. (2001). Venous Thromboembolism and Occult Malignancy. Thrombosis Research. 102(6). V187–V194. 76 indexed citations

20.

Otten, Hans‐Martin, Martin H. Prins, Susanne M. Smorenburg, & Barbara A. Hutten. (2000). Risk Assessment and Prophylaxis of Venous Thromboembolism in Non-Surgical Patients: Cancer as a Risk Factor. Pathophysiology of Haemostasis and Thrombosis. 30(Suppl. 2). 72–76. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact